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Although I don’t have any objective data, I would bet that
peer review of medical scientific publications must rank near
the bottom of the list of topics of interest to the general
public. It would be hard to imagine that editorial peer
review would ever be the focus of a Robin Cook thriller or
be the cover story of one of the weekly news magazines.
Nevertheless, the June 4 New York Times devoted an entire
feature article to the topic by lead medical writer, Lawrence
Altman, MD. Although the piece was accurate, from my
admittedly sensitive position, it seemed to be a harsh
assessment. Quoting the then Editor of the British Medical
Journal, Dr. Steven Lock, Altman admonished that “Edi-
tors, the arbiters of rigor, quality and innovativeness in
publishing scientific work, do not apply to their own work
the standards they apply to judging the work of others.”
The stimulus for the article in the New York Times was
the publication of the Proceedings of the Fourth Interna-
tional Congress of Peer Review in Biomedical Publication
in the June 5 issue of the Journal of the American Medical
Association (JAMA). Scheduled as it was in the days imme-
diately following September 11, the meeting was absent
some participants (primarily American). Nevertheless, 40 of
43 scheduled presentations were delivered, and 58 of 65
posters were presented. Organized under the sponsorship of
JAMA and the direction of Dr. Drummond Rennie, Deputy
Editor, the conference presented data resulting from sys-
tematic studies of the editorial peer-review process. Topics
discussed included Authorship and Contributorship, Edi-
torial Peer Review, Bias, Ethical and Legal Issues, and
E-Journals and On-Line Information. Not surprisingly,
most of the studies were carried out by editors or those
involved with current medical journals. In aggregate, the
Congress and Proceedings represent a serious attempt by
those responsible to address problems in, and improve the
system of, editorial peer review.
Dr. Altman utilized the occasion of the JAMA publica-
tion to lament the shortcomings of peer review as practiced
by current medical journals. He indicated that, despite the
time and expense required for peer review, data are some-
times published which are erroneous, plagiarized, or even
fraudulent. Moreover, the process occasionally fails to iden-
tify work of exceptional importance, as evidenced by rejec-
tions of Jenner’s report of the first development of smallpox
vaccine as well as two other papers whose authors were
subsequently awarded the Nobel Prize. These failings were
at least partly attributed to the fact that reviewers did not
examine the original raw data from the experiments. Errors
in statistical analysis were pointed to as a frequent occur-
rence in scientific papers. Finally, Dr. Altman observed that
authors sometimes overinterpret the implications of their
findings and fail to acknowledge their limitations, both in
their papers and in communications with the lay press.
That the above missteps of editorial peer review exist at
all is problem enough. However, Dr. Altman observes that
a journal’s decision to publish a manuscript has evolved over
the years into a sort of “Good Housekeeping Seal of
Approval,” conveying legitimacy upon a manuscript that
may not be deserved. He regrets the fact that journals
restrict communication of research findings to the lay press
until after publication, a process that may slow the flow of
information. Also pointed out, as has been recognized for
many years, was the fact that most manuscripts that are
rejected by one journal ultimately appear in another. Thus,
peer review seems often to determine where papers are
published, rather than which papers.
It is not my purpose here to provide a point-by-point
response to Dr. Altman’s critique of editorial peer review.
However, a few brief observations do seem in order. It is
true that actual raw data are not evaluated in peer review,
but representative illustrations of raw data are submitted for
most papers. Considering the large number of submissions,
it would clearly be logistically impossible for any journal to
review the actual raw data for all papers received. Even were
this feasible, it would often still be impossible to verify that
the experiments had actually been performed in the manner
described. However, we can take consolation in the fact that
all truly important findings are subjected to the crucible of
reproduction, and those that fail are ultimately discarded. It
should also be recognized that rejection of a manuscript
certainly does not mean that it is without merit. JACC is
currently able to publish less than 20% of the submitted
papers, and many that fail to achieve adequate priority are of
considerable value. Nevertheless, by prioritizing papers, peer
review directs manuscripts to journals with more appropri-
ate audiences and provides readers with the advice of experts
as to which communications are apt to be of greatest
importance. With the explosion of medical literature, even
specialists cannot read everything written in their field.
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With regard to embargo of articles to the press, it seems
apparent that the lay public is often not sufficiently knowl-
edgeable to interpret the significance of new research data.
Reason would therefore dictate that physicians have the
opportunity to read new reports first, so that they can
interpret them for patients, tempering both the unrealistic
fears and unrealistic expectations of their patients. In fact, it
was surprising that Dr. Altman would want the press and
patients to have immediate access to new research reports,
many of which he fears exaggerate their importance and
neglect their limitations. In terms of the charge that
landmark advances such as Jenner’s development of vacci-
nation are occasionally rejected, every editor I have met
acknowledged that the peer-review process is fallible. Some-
times editorial decisions lead to embarrassing mistakes,
putting this endeavor in company with many other aspects
of daily life. However, even this imperfection has a silver
lining; it ensures the humility of editors and provides
reassurance to authors that rejection of any of their papers
was likely one of the erroneous decisions.
As stated earlier, it is neither necessary for me, nor my
responsibility, to defend peer review. There is no doubt in
my mind that the editorial system has definite limitations
and that Dr. Altman does a service in reminding us of this.
As an editor, reviewer, author, and reader I have experi-
enced many of these limitations firsthand. Nevertheless,
peer review has survived some 200 years as the cornerstone
of medical literature. I believe the reason for this is a
characteristic it shares with democracy. Specifically, just as
democracy is the “worst form of government . . . except for
all others,” so editorial peer review is the worst system for
the scientific literature . . . except for the alternatives. Al-
though modifications such as unblinded reviews, publication
of reviews with manuscripts, and even publication of virtu-
ally all submitted manuscripts (at least on-line) have been
proposed, and may yet be incorporated, they have thus far
either failed to demonstrate benefit or have not been
embraced by authors and readers. Despite its imperfections,
even critics admit that the peer-review process often results
in removal of errors and significant improvement in pub-
lished papers, and it occasionally salvages manuscripts that
may otherwise have been lost.
My initial Editor’s Page indicated my belief that medical
literature and journals will undergo dramatic change over
the next decade. Nevertheless, the fundamental functions
fulfilled by peer review are likely to persist. I believe that
readers will continue to seek guidance as to the most
original, accurate, and relevant literature to read and that
authors will continue to compete for this audience and for
the recognition that this designation conveys. Moreover, I
continue to think that arbitration by an objective editor of
the critiques of expert reviewers will still be the method by
which new research is prioritized for publication and im-
proved in presentation. While physicians who read journals
must remain cognizant of the imperfections of peer review,
I believe that this process will continue to be the cornerstone
of the medical literature. With all its flaws, editorial peer
review is still superior to all the alternatives.
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